India said Monday it will resume exporting domestically produced COVID-19 vaccines to other nations, five months after it suspended exports of AstraZeneca shots amid a devastating wave of infections. Meanwhile, a new study finds wealthy nations have stockpiled more vaccines than their populations are willing to consume, with about 100 million doses set to expire, unused, by the end of the year.